Sector News

ChemChina gains approval for Syngenta acquisition from US competition authority

April 5, 2017
Energy & Chemical Value Chain

ChemChina (Beijing) and Syngenta (Basel) today announced that they have received approval from the US Federal Trade Commission (FTC) for the proposed $43 billion acquisition of Syngenta by ChemChina.

This represents a major step towards the closing of the transaction, which is expected to take place in the second quarter of 2017, Syngenta says. Approval from the EU Commission, expected this month, is the last major hurdle for the deal, first announced in February 2016. “The ChemChina-Syngenta transaction will ensure continued choice and ongoing innovation for growers in the USA and around the world,” Syngenta said today.

To secure FTC approval, the companies agreed to divest ChemChina’s generic production of the herbicide paraquat, used to clear fields prior to growing seasons; the insecticide abamectin, used on citrus and tree nut crops by killing mites, psyllid, and leafminers; and the fungicide chlorothalonil, used for peanut and potato crops.

Syngenta is a producer of the branded versions of the three pesticides, giving it significant market shares in the US, while Adama (Tel Aviv), ChemChina’s generic agchems producer, sells the generic versions to US farmers. Adama is among the leading generics suppliers in the US for each of these products.

Without the proposed divestment, the merger would eliminate the direct competition that exists today between ChemChina’s generics subsidiary Adama and Syngenta’s branded products. The merger would also increase the likelihood that US customers buying paraquat, abamectin, and chlorothalonil would be forced to pay higher prices or accept reduced service for these products, the FTC says. The deal is subject to ChemChina selling all rights and assets of Adama’s US paraquat, abamectin and chlorothalonil agchem businesses to AMVAC (Newport Beach, California). Syngenta and Adama control about 25% of the global agchems market.

The deal with ChemChina has received approvals from many global jurisdictions and is awaiting clearance from the EU, China, India and Mexico, Syngenta says.

The ChemChina-Syngenta transaction is one of three major deals in the consolidation of the global agchems industry. The other deals are a proposed merger of Dow Chemical and DuPont and Bayer’s plan to merge with Monsanto.

By Natasha Alperowicz

Source: Chemical Week

comments closed

Related News

April 26, 2024

CIECH Group will change its name to Qemetica in June

Energy & Chemical Value Chain

We are closing the chapter of the Chemicals Import Export Headquarters, and opening a new chapter under the name of Qemetica – a chemical group driving many industries on all continents. Therefore, the change of name is also accompanied by the adoption of the key goals of the business strategy for the next 6 years. – says Kamil Majczak, President of the Management Board.

April 26, 2024

Neste annouces first success in processing pyrolysis oil from discarded tires

Energy & Chemical Value Chain

In its efforts to advance chemical recycling, Neste has successfully conducted its first processing trial run with a new challenging raw material, liquefied discarded tires. In the processing run, Neste produced high-quality raw material for new plastics and chemicals.

April 26, 2024

Sika opens synthetic fibers production facility in Peru

Energy & Chemical Value Chain

Sika is opening a state-of-the-art facility in Lima, Peru, to produce synthetic macro fibers, and expanding the rollout of a product range with great growth potential in Latin America. With this innovative technology, Sika is further strengthening its position as a leading supplier to the mining industry and a strong partner for infrastructure projects.

How can we help you?

We're easy to reach